Synthesis and antioxidant capacity of 5-selenopyranose derivatives

Chemical Communications

Volumn 47, Issue 34, 2011, Pages 9693-9695

  Storkey, Corin ^a,b,c,d   Davies, Michael J ^a,c   White, Jonathan M ^b   Schiesser, Carl H ^a,b  

^a Australian Government Australian Research Council   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HEART RESEARCH INSTITUTE   (Australia)

^d University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN DERIVATIVE; 1,5 DIDEOXY 5 SELENO DEXTRO PYRANOSE; 1,5 DIDEOXY 5 THIO DEXTRO PYRANOSE; ANTIOXIDANT; CARBOHYDRATE DERIVATIVE; DEXTRO MANNODEOXYNOJIRIMYCIN; HYDROXYL GROUP; HYPOCHLOROUS ACID; LEVO GULODEOXYNOJIRIMYCIN; MESYLIC ACID DERIVATIVE; METHIONINE; ORGANOSELENIUM DERIVATIVE; PHTHALALDEHYDE; PLASMA PROTEIN; SELENIDE; SULFIDE; SULFUR DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPROTECTION REACTION; DERIVATIZATION; DOSE RESPONSE; DRUG SYNTHESIS; EPIMERIZATION; HUMAN; OXIDATION REDUCTION REACTION; PLASMA; PROCESS OPTIMIZATION; STEREOCHEMISTRY; SUBSTITUTION REACTION;

EID: 80051750460     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c1cc13652f     Document Type: Article

References (25)

1. J. T. Rotruck A. L. Pope H. E. Ganther A. B. Swanson D. G. Hafeman W. G. Hoekstra Science 1973 179 4073 588 590
2. D. Mustacich G. Powis Biochem. J. 2000 346 1 1 8
3. K. Schwarz Fed. Proc. 1961 20 666 673
4. G. Mugesh H. B. Singh Chem. Soc. Rev. 2000 29 347 357
5. T. Schewe Gen. Pharmacol. 1995 26 6 1153 1169
6. A. E. Stutz, Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond, Wiley-VCH, New York, 1999
7. S. G. Withers M. Namchuk R. Mosi Iminosugars Glycosidase Inhib. 1999 188 206
8. N. Asano Cell. Mol. Life Sci. 2009 66 9 1479 1492
9. R. L. Whistler W. C. Lake Biochem. J. 1972 130 4 919 925
10. J. H. Kim S. H. Kim E. W. Hahn C. W. Song Science 1978 200 4338 206 207
11. P. B. Fischer M. Collin G. B. Karlsson W. James T. D. Butters S. J. Davis S. Gordon R. A. Dwek F. M. Platt J. Virol. 1995 69 9 5791 5797
12. B. M. Pinto, B. D. Johnston, A. Ghavami, M. G. Szczepina, H. Liu and K. Sadalapure Preparation of salacinol sulfate-containing alditols as glycosidase inhibitors and antidiabetic agents. 2004-CA958, 2004
13. T. Van Es R. L. Whistler Tetrahedron 1967 23 6 2849 2853
14. M. A. Lucas O. T. K. Nguyen C. H. Schiesser S.-L. Zheng Tetrahedron 2000 56 24 3995 4000
15. C. H. Schiesser S.-L. Zheng Tetrahedron Lett. 1999 40 27 5095 5098
16. O. T. K. Nguyen C. H. Schiesser Tetrahedron Lett. 2002 43 21 3799 3800
17. J. Gelas D. Horton Carbohydr. Res. 1978 67 2 371 387
18. A. Hoy B. Leininger-Muller D. Kutter G. Siest S. Visvikis Clin. Chem. Lab. Med. 2002 40 1 2 8
19. A. Van Der Vliet M. N. Nguyen M. K. Shigenaga J. P. Eiserich G. P. Marelich C. E. Cross Am. J. Physiol. Lung Cell Mol. Physiol. 2000 279 3 L537 546
20. J. M. S. Davies D. A. Horwitz K. J. A. Davies Free Radical Biol. Med. 1993 15 6 637 643
21. F. J. Kelly I. S. Mudway Amino Acids 2003 25 3-4 375 396
22. E. Malle T. Buch H.-J. Grone Kidney Int. 2003 64 6 1956 1967
23. H. Ohshima M. Tatemichi T. Sawa Arch. Biochem. Biophys. 2003 417 1 3 11
24. M. J. Davies C. L. Hawkins D. I. Pattison M. D. Rees Antioxid. Redox Signaling 2008 10 7 1199 1234
25. D. I. Pattison C. L. Hawkins M. J. Davies Chem. Res. Toxicol. 2009 22 5 807 817